Home Medivir

Medivir

Medivir Enrollment Completed in the MIV-711 Osteoarthritis Extension Study and Data Monitoring Committee Recommendation

Medivir AB (Nasdaq Stockholm: MVIR) today announced continued progress towards the completion of its phase IIa program...